SOUTH WINDSOR, CT -- During a ceremony held at Gerber Scientific, Inc.’s (NYSE: GRB) headquarters, 45 United States patents were presented to 42 employees from each of the company’s four subsidiaries, in recognition of their accomplishments in innovation. This includes three patents awarded posthumously to Joseph Gerber, founder of the company.

Twenty patents were awarded to employees of Gerber Scientific Products, a developer and manufacturer of systems, software, materials and accessories to the sign making and specialty graphics industry, fourteen to Gerber Technology, a provider of automation solutions to apparel and flexible goods industries, six to Gerber Coburn, a provider of computer-integrated lens processing systems to the ophthalmic industry, and five to Gerber Innovations, a designer and developer of products and processes that extend Gerber’s technology and intellectual property into new markets.

"Gerber Scientific has a powerful history of innovation in multiple industries," said Marc Giles, President and Chief Executive Officer of Gerber. "Joe Gerber alone held nearly 700 patents in his lifetime. His legacy continues and manifests itself in each of you. Today, we have hundreds of truly unique products on the market, each of which addresses our customers’ need for improved efficiencies, quality and profitability. With each passing year, we introduce new products designed and engineered according to the direction we receive from our customers."

Gerber Scientific, Inc. currently holds more than one thousand active patents.

In addition to the historical information contained herein, there are matters discussed that are considered to be "forward-looking statements." The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. These forward-looking statements involve risks and uncertainties, including, but not limited to, economic, competitive, governmental, and technological factors affecting the Company’s operations, markets, products, and services, that could significantly affect results in the future. For a discussion of other risk factors relating to the Company’s business, see the Company’s Quarterly Reports on Form 10-Q for the quarters ended July 31, 2002 and October 31, 2002, and its Annual Report on Form 10-K for the year ended April 30, 2002, as filed with the Securities and Exchange Commission. The forward-looking statements contained in this release are made as of the date of this release, and the Company assumes no obligation to update or revise any forward-looking statements contained in this release.